GeneDx Holdings Corp. (WGS) Return on equity 2021–2025
GeneDx Holdings Corp. (WGS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.8%FY2025 · since FY2021: -63.2% → -6.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.8% | +14.5 pp |
| FY2024 | -21.3% | +55.8 pp |
| FY2023 | -77.1% | +139.3 pp |
| FY2022 | -216.4% | -153.2 pp |
| FY2021 | -63.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice